SCHEMBL6153810

SCHEMBL6153810

O=C(O)c1cccc(Oc2cccc(-c3nnc(Nc4ccc(Cl)c(Cl)c4)s3)c2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.55
ROCK1 Q13464 3/20 0.54
ROCK2 O75116 2/20 0.54
GUSB P08236 2/20 0.53
KMT2A Q03164 2/20 0.46
BLM P54132 4/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
CBS P35520 1/20 0.45
HDAC6 Q9UBN7 1/20 0.44
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
GAA P10253 1/20 0.43
DNMT1 P26358 1/20 0.43
HTT P42858 1/20 0.43
DUSP3 P51452 1/20 0.43
CACNA1B Q00975 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4954816 0.90 GUSB (0.56) KMOROCK1ROCK2GUSBKMT2A
SCHEMBL6155142 0.88 GUSB (0.60) ROCK1ROCK2GUSBKMT2ABLM
SCHEMBL6154359 0.87 GUSB (0.65) KMOROCK1ROCK2GUSBKMT2A
SCHEMBL6153472 0.86 GUSB (0.53) ROCK1ROCK2GUSBKMT2ABLM
SCHEMBL6153840 0.84 GUSB (0.58) ROCK1ROCK2GUSBKMT2ABLM
SCHEMBL6154398 0.84 MAPT (0.45) ROCK1ROCK2GUSBKMT2ANPC1
SCHEMBL6154406 0.84 MAPT (0.45) ROCK1ROCK2GUSBKMT2ANPC1
SCHEMBL6154309 0.84 GUSB (0.58) ROCK1ROCK2GUSBKMT2ABLM
SCHEMBL6153683 0.84 GUSB (0.51) ROCK1ROCK2GUSBKMT2ABLM
SCHEMBL6155427 0.83 GUSB (0.50) ROCK1ROCK2GUSBKMT2ABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US claimed
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP KMO 2929/4885ROCK1 3290/4885ROCK2 3224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.